Sofia Haserot
Physician Assistant · Beverly Hills, CANPI 1225626039
Payments from drug & device makers
Across 173 payments — averaging $22.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$697
- Novartis$523
- Bayer$386
- Edwards Lifesciences$309
- ANI Pharmaceuticals, Inc.$272
- Boehringer Ingelheim$240
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,825100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 35 | $697 |
| Novartis | 27 | $523 |
| Bayer | 15 | $386 |
| Edwards Lifesciences | 11 | $309 |
| ANI Pharmaceuticals, Inc. | 11 | $272 |
| Boehringer Ingelheim | 11 | $240 |
| Novo Nordisk | 7 | $175 |
| Mallinckrodt Hospital Products Inc. | 5 | $147 |
| AstraZeneca | 7 | $138 |
| Lilly USA, LLC | 6 | $119 |
| Verona Pharma, Inc. | 4 | $114 |
| GSK | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $72 |
| Mylan Specialty L.p. | 3 | $60 |
| Lexicon Pharmaceuticals, Inc. | 3 | $58 |
| Heartflow, Inc. | 3 | $51 |
| Esperion Therapeutics, Inc. | 3 | $50 |
| Ardelyx, Inc. | 2 | $49 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $45 |
| Exact Sciences | 2 | $42 |
| Dexcom, Inc. | 1 | $26 |
| Amarin Pharma, Inc. | 1 | $24 |
| Boston Scientific | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$3,825 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 25 | $18,428 |
| Sevelamer Carbonate | 11 | $2,146 |
| Paricalcitol | 13 | $1,714 |
| Amlodipine Besylate | 31 | $422 |
| Nifedipine ErNifedipine | 15 | $409 |
| Torsemide | 11 | $360 |
| Carvedilol | 20 | $291 |
| Lisinopril | 21 | $256 |
| Atorvastatin Calcium | 20 | $249 |
| Allopurinol | 21 | $170 |
| Furosemide | 22 | $154 |
| Zolpidem Tartrate | 12 | $151 |
| Rosuvastatin Calcium | 15 | $110 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $138 | $18,42825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.
Other physician assistant in Beverly Hills
- William FloresBeverly Hills$103K
- Anne LeeBeverly Hills$73K
- Kristin PolegaBeverly Hills$43K
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.